AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Corvus Pharmaceuticals, Inc. Director's Dealing 2016

Mar 22, 2016

32755_dirs_2016-03-22_7f299c56-7bad-4bdc-b1b5-7b8c3e99ab61.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Corvus Pharmaceuticals, Inc. (CRVS)
CIK: 0001626971
Period of Report: 2016-03-22

Reporting Person: Jones William Benton (VP Pharmaceutical Development)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, $0.0001 par value	113773	Direct

Footnotes

F1: A portion of these shares is subject to a right of repurchase held by the Issuer.